Clinical Trials Browser

INDUSTRY × Lymphoma, Non-Hodgkin × palbociclib × Clear all

NCT00141297 2016-01-05

A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer

Phase 1 Completed

74 enrolled 34 charts

Lymphoma, Non-Hodgkin, Neoplasms